Related Experiment Videos
Preparation and characterization of solid lipid nanoparticles containing cloricromene
M L Bondì1, G Fontana, B Carlisi
1Istituto per lo Studio dei Materiali Nanostrutturati, sez. di Palermo, Consiglio Nazionale delle Ricerche, Palermo, Italy.
Drug Delivery
|November 13, 2003
Summary
Solid lipid nanoparticles (SLN) effectively deliver cloricromene, with rapid release in human plasma. This suggests SLN are promising for targeted drug delivery to the central nervous system.
Area of Science:
- Pharmaceutical Sciences
- Nanotechnology
- Drug Delivery
Background:
- Solid lipid nanoparticles (SLN) are investigated as advanced colloidal carriers.
- Cloricromene is a drug candidate requiring effective delivery systems.
Purpose of the Study:
- To develop and characterize SLN for cloricromene encapsulation.
- To evaluate the in vitro drug release profile of cloricromene from SLN.
Main Methods:
- SLN were prepared using microemulsion or precipitation techniques.
- In vitro drug release studies were conducted under conditions simulating body fluids (pH 7.4, human plasma).
Main Results:
- High in vitro drug release rates for cloricromene were observed at pH 7.4 and in human plasma.
- Approximately 70% of cloricromene was released within 15 minutes in human plasma.
- Unreleased cloricromene remained encapsulated within the SLN after 4 hours.
Conclusions:
- The developed SLN system demonstrates efficient encapsulation and controlled release of cloricromene.
- The rapid release in plasma suggests potential for systemic drug delivery.
- SLN show promise for targeted central nervous system drug delivery via intravenous administration.